JP2024512135A5 - - Google Patents
Info
- Publication number
- JP2024512135A5 JP2024512135A5 JP2023560358A JP2023560358A JP2024512135A5 JP 2024512135 A5 JP2024512135 A5 JP 2024512135A5 JP 2023560358 A JP2023560358 A JP 2023560358A JP 2023560358 A JP2023560358 A JP 2023560358A JP 2024512135 A5 JP2024512135 A5 JP 2024512135A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- cdr
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163168605P | 2021-03-31 | 2021-03-31 | |
| US202163168611P | 2021-03-31 | 2021-03-31 | |
| US202163168621P | 2021-03-31 | 2021-03-31 | |
| US202163168618P | 2021-03-31 | 2021-03-31 | |
| US202163168628P | 2021-03-31 | 2021-03-31 | |
| US63/168,618 | 2021-03-31 | ||
| US63/168,621 | 2021-03-31 | ||
| US63/168,611 | 2021-03-31 | ||
| US63/168,605 | 2021-03-31 | ||
| US63/168,628 | 2021-03-31 | ||
| PCT/US2022/022500 WO2022212470A2 (en) | 2021-03-31 | 2022-03-30 | Materials and methods for immune effector cells redirection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512135A JP2024512135A (ja) | 2024-03-18 |
| JP2024512135A5 true JP2024512135A5 (https=) | 2025-04-07 |
Family
ID=83459998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560358A Pending JP2024512135A (ja) | 2021-03-31 | 2022-03-30 | 免疫エフェクター細胞再指向のための材料及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240182582A1 (https=) |
| EP (1) | EP4314080A4 (https=) |
| JP (1) | JP2024512135A (https=) |
| KR (1) | KR20230163485A (https=) |
| AU (1) | AU2022246607A1 (https=) |
| BR (1) | BR112023020249A2 (https=) |
| CA (1) | CA3214963A1 (https=) |
| IL (1) | IL307312A (https=) |
| MX (1) | MX2023011645A (https=) |
| TW (1) | TW202304992A (https=) |
| WO (1) | WO2022212470A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250017240A (ko) * | 2022-05-27 | 2025-02-04 | 사노피 | FC-조작을 갖는 NKp46 및 BCMA 변이체에 결합하는 자연 살해(NK) 세포 관여자 |
| WO2024208818A1 (en) | 2023-04-04 | 2024-10-10 | Innate Pharma | Modular chimeric antigen receptor |
| US12286475B2 (en) | 2023-07-31 | 2025-04-29 | Sanofi | Anti-GPRC5D antibodies and compositions |
| WO2025122929A1 (en) * | 2023-12-08 | 2025-06-12 | Janssen Biotech, Inc. | Gprc5d antibodies with enhanced effector function and uses thereof |
| WO2025137555A1 (en) * | 2023-12-20 | 2025-06-26 | Omniab, Inc. | Polypeptides that bind to nkp46 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291714B1 (en) * | 1999-06-30 | 2007-11-06 | Millennium Pharmaceuticals, Inc. | Glycoprotein VI and uses thereof |
| WO2007048186A1 (en) * | 2005-10-25 | 2007-05-03 | Baker Medical Research Institute | Leukocyte-binding polypeptides and uses thereof |
| AU2008337517B2 (en) * | 2007-12-14 | 2014-06-26 | Novo Nordisk A/S | Antibodies against human NKG2D and uses thereof |
| WO2010017103A2 (en) * | 2008-08-04 | 2010-02-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Fully human anti-human nkg2d monoclonal antibodies |
| WO2011085178A1 (en) * | 2010-01-11 | 2011-07-14 | Trustees Of Dartmouth College | Monomeric bi-specific fusion protein |
| CA2875543A1 (en) * | 2012-06-21 | 2013-12-27 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind igf1r |
| US11227669B2 (en) * | 2014-06-21 | 2022-01-18 | Norbert Ikechukwu Nwankwo | Computer aided drug resistance calculator calculating drug resistance using amprenavir as a case study |
| JP6822849B2 (ja) * | 2014-06-27 | 2021-01-27 | イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． | 多重特異的ＮＫｐ４６結合タンパク質 |
| AU2017237543B2 (en) * | 2016-03-23 | 2020-02-06 | Institut Pasteur Korea | Antibody that binds to envelope glycoprotein of severe fever with thrombocytopenia syndrome virus, and use for same |
| AU2018219887B2 (en) * | 2017-02-08 | 2024-08-15 | Dragonfly Therapeutics, LLC | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
| CN110461361A (zh) * | 2017-02-10 | 2019-11-15 | 蜻蜓治疗公司 | 结合bcma、nkg2d和cd16的蛋白 |
| JP7350756B2 (ja) * | 2018-02-14 | 2023-09-26 | アバ セラピューティクス アーゲー | 抗ヒトｐｄ－ｌ２抗体 |
| EP3765516A2 (en) * | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
| CA3099308A1 (en) * | 2018-05-21 | 2019-11-28 | Compass Therapeutics Llc | Compositions and methods for enhancing the killing of target cells by nk cells |
| EA202091977A1 (ru) * | 2018-05-28 | 2021-02-09 | Драгонфлай Терапьютикс, Инк. | Мультиспецифические связывающие белки, которые связывают cd33, nkg2d и cd16, и способы применения |
| HRP20240821T1 (hr) * | 2018-08-27 | 2024-09-27 | Affimed Gmbh | Stanice nk čuvane zamrzavanjem, koje su prethodno ubačene uz protutijelni konstrukt |
| BR112022001368A2 (pt) * | 2019-07-26 | 2022-05-24 | Janssen Biotech Inc | Proteínas que compreendem domínios de ligação ao antígeno de peptidase 2 relacionada à calicreína e seus usos |
| CA3248329A1 (en) * | 2019-07-31 | 2025-11-29 | F. Hoffmann-La Roche Ag | Antibodies binding to gprc5d |
| CN110903402B (zh) * | 2019-11-27 | 2023-02-28 | 中国药科大学 | 一种双特异性融合蛋白及其构建方法与应用 |
-
2022
- 2022-03-30 JP JP2023560358A patent/JP2024512135A/ja active Pending
- 2022-03-30 US US18/284,586 patent/US20240182582A1/en active Pending
- 2022-03-30 AU AU2022246607A patent/AU2022246607A1/en not_active Abandoned
- 2022-03-30 WO PCT/US2022/022500 patent/WO2022212470A2/en not_active Ceased
- 2022-03-30 EP EP22782075.0A patent/EP4314080A4/en active Pending
- 2022-03-30 MX MX2023011645A patent/MX2023011645A/es unknown
- 2022-03-30 BR BR112023020249A patent/BR112023020249A2/pt not_active Application Discontinuation
- 2022-03-30 TW TW111112186A patent/TW202304992A/zh unknown
- 2022-03-30 CA CA3214963A patent/CA3214963A1/en active Pending
- 2022-03-30 KR KR1020237036859A patent/KR20230163485A/ko active Pending
- 2022-03-30 IL IL307312A patent/IL307312A/en unknown